Notification of decision to issue a licence on application - posted 19 August 2010
PDF 42 KB
HTML
Questions & Answers
PDF 19 KB
HTML
Risk Assessment and Risk Management Plan (RARMP) Executive Summary
PDF 42 KB
HTML
Risk Assessment and Risk Management Plan (RARMP) Technical Summary
PDF 51 KB
HTML
Full Risk Assessment and Risk Management Plan (RARMP) for the commercial release of a genetically modified live viral vaccine to protect against Japanese Encephalitis (IMOJEV®)
PDF 669 KB
HTML
Licence application summary
PDF 68 KB
HTML
GM Vaccine Licence Conditions
PDF 269 KB
HTML